The International Vaccine Institute (IVI) is an independent, Nonprofit, international organization that was founded on the belief that the health of children in developing countries can be dramatically improved by the use of new and improved vaccines.
| Founder | United Nations Development Programme |
|---|---|
| Type | International_organization |
| Purpose | Discover, develop, and deliver safe, effective, and affordable vaccines for global public health. |
| Headquarters | Seoul, Republic of Korea |
|
Membership
|
35 member states and the World Health Organization |
- IVI, an International Organisation is headquartered at Seoul, South Korea and established based on the initiatives of UNDP.
- It is devoted to developing and introducing new and improved vaccines to protect the people against infectious diseases.
India and IVI
- India is a long-term collaborator and stakeholder of IVI since 2007.
- With the change in governance structure in 2012, India becomes a full member of its governing council with the cabinet approval.
- One of the most successful collaborations of IVI with India was on the development of Shanchol, the world‘s first low-cost oral cholera vaccine.
- The vaccine was licensed in India in 2009 and WHO-prequalified in 2011.
- The Indian Council of Medical Research (ICMR) has signed a MoU with the International Vaccine Institute (IVI) for collaborating on vaccine research and development.